The best-performing company of them all? Well, according to BusinessWeek, it’s a biopharmaceutical company, Gilead Sciences, which placed first in the annual BusinessWeek 50. The company posted some impressive numbers: a 48.6 percent pretax profit as a percentage of average invested capital (taken as an average of the last three years), 38.2 average annual sales growth, and three-year total return of 43.9 percent.
Gilead, of course, is a company we’ve long been watching with interest. Here, for example, is Bill Trombetta’s look at the company in last year’s “Stealth Pharma” analysis.